What is Jazz Pharmaceuticals's clinical trial accruals?

Jazz Pharmaceuticals (JAZZ) reported clinical trial accruals of $38.2M in Q1 2026.

How has Jazz Pharmaceuticals's clinical trial accruals changed year-over-year?

Jazz Pharmaceuticals's clinical trial accruals increased by 16.8% year-over-year, from $32.7M to $38.2M.

What is the long-term trend for Jazz Pharmaceuticals's clinical trial accruals?

Over 3 years (2022 to 2025), Jazz Pharmaceuticals's clinical trial accruals has grown at a 10.3% compound annual growth rate (CAGR), from $31.34M to $42M.

Jazz Pharmaceuticals JAZZ Clinical trial accruals

Other financials

Income statement

See full

Revenue$1.1B+19.1%

Operating income$336.6M+702%

Net income$293.1M+417%

EPS (diluted)$4.43+391%

Balance sheet

See full

Cash & equivalents$667.5M-64.1%

Total debt$5.4B-0.1%

Total equity$4.5B+8.6%

Total assets$11.9B+2.8%

Cash flow

See full

Operating cash flow$408.2M-5.0%

CapEx$19.7M+41.7%

Free cash flow$388.5M-6.6%

Valuation

See full

Market cap$14.11B+54.4%

Enterprise value$18.85B+47.7%

P/S3.2×+0.9×

Profitability

See full

Operating margin-11.9%-28.1pp

Net margin-8.9%-20.5pp

FCF margin28.6%-8.6pp

Returns & leverage

See full

Return on equity-9.1%-21.2pp

Debt / equity1.2×-0.1×

Current ratio2×-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept jazz:AccruedClinicalTrialLiabilityCurrent.

The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's clinical trial accruals.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Jazz Pharmaceuticals's clinical trial accruals?: Jazz Pharmaceuticals (JAZZ) reported clinical trial accruals of $38.2M in Q1 2026.
How has Jazz Pharmaceuticals's clinical trial accruals changed year-over-year?: Jazz Pharmaceuticals's clinical trial accruals increased by 16.8% year-over-year, from $32.7M to $38.2M.
What is the long-term trend for Jazz Pharmaceuticals's clinical trial accruals?: Over 3 years (2022 to 2025), Jazz Pharmaceuticals's clinical trial accruals has grown at a 10.3% compound annual growth rate (CAGR), from $31.34M to $42M.